Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.

• Unité de recherche: INNOSUISSE
• Numéro de projet: 29722.1 IP-LS
• Titre du projet anglais: Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.

Description succincte (Allemand)

Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.

Description succincte (Anglais)

Molecular target validation and profiling of a novel class of anti-triple-negative breast cancer (TNBC) small-molecule Wnt pathway inhibitors.

Résumé des résultats (Abstract) (Allemand)

This project aims to validate and provide necessary data on the molecular target(-s) of our novel anti-Wnt signaling scaffold demonstrating excellent anti-cancer properties and safety profile. These data are essential for their acceptance and further structure-driven development in pharma companies.